Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (6)

1

Correction : GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review

enthalten in: Blood cancer journal | 2024

von Rodriguez-Otero, P. | van de Donk, N. | Pillarisetti, K. | +13

ErratumFor: Blood Cancer J. 2024 Feb 2;14(1):24. - PMID 38307865

2

GPRC5D as a novel target for the treatment of multiple myeloma : a narrative review

enthalten in: Blood cancer journal | 2024

von Rodriguez-Otero, P. | van de Donk, N. | Pillarisetti, K. | +13

ErratumIn: Blood Cancer J. 2024 Mar 6;14(1):40. - PMID 38448422

3

Increased mortality risk in multiple-myeloma patients with subsequent malignancies : a population-based study in the Netherlands

enthalten in: Blood cancer journal | 2022

von Brink, M. | Minnema, M. | Visser, O. | +12

4

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

enthalten in: Blood cancer journal | 2022

von Cohen, A. | Parekh, S. | Santomasso, B. | +22

5

Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands : a population-based study

enthalten in: Blood cancer journal | 2021

von Brink, M. | Groen, K. | Sonneveld, P. | +10

6

First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands : a population-based study, 1989-2018

enthalten in: Blood cancer journal | 2021

von Brink, M. | Visser, O. | Zweegman, S. | +4

1
[1]